Aegerion slashes workforce; GSK president says downward pressure on drug prices is here to stay; Novartis acquires European rights to Remicade biosimilar
Sanofi is the first to announce the launch of a R&D program for Zika as other pharma companies are assessing whether to join the development race.
Copaxone sales fall; Mylan to acquire Swedish drugmaker; health insurers report financial losses from ACA plans
She is the first chief marketing officer for Shatterproof.
The FDA is set to announce its decision on the drug in April.
Lions Health, launched in 2014, generated $1.9 million in revenue last year.
SEC is investigating Salix Pharmaceuticals; FDA adcomm recommends approval of Remicade biosimilar; Medicare considers payment changes
The campaign targets 86 million Americans, 90% of whom aren't aware they have the condition.
The FDA to review biosimilar Remicade; lawmaker looks at panelists' ties to painkiller manufacturers; Novartis signs risk-sharing contracts for Entresto
The newly launched tools aim to reduce the time and costs of marketing new drugs by "debugging" the lab environment.